TY - JOUR T1 - Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2021-003149corr1 VL - 9 IS - 10 SP - e003149corr1 A2 - , Y1 - 2021/10/01 UR - http://jitc.bmj.com/content/9/10/e003149corr1.abstract ER -